Equity compensation through stock acquisition rights for directors and audit & supervisory board members
First written in FY2017-Q2. 5 of 7 entries say "Advanced", first in FY2017. Latest entry: FY2019-Q2.
No other company in this theme has enough history to compare yet.
- FY2019-Q2DroppedAnnual report
「Based on a resolution adopted at the 71st Annual General Meeting of Shareholders held on 28 June 2018, the company abolished its stock option plan for directors, excluding outside directors, and audit & supervisory board members, excluding outside audit & supervisory board members, collectively referred to below as the "Directors, etc.," and introduced a new equity compensation plan for the Directors, etc., called the "Share Delivery Trust for Officers" (the "Plan").」
The company abolished the former stock option plan for directors and audit & supervisory board members and replaced it with a new equity compensation plan. - FY2019-Q1AdvancedAnnual report
「1 April 2018–30 June 2018 (Note) 9,000 8,347,078 2,982 2,854,934 2,982 3,023,334 (Note) Increase resulting from the exercise of stock acquisition rights.」
In the first quarter, the number of shares increased by 9,000 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥2.982 million. - FY2018AdvancedAnnual report
「Number of stock acquisition rights (units): 28 Number of shares underlying the stock acquisition rights (shares): 14,000 Exercise period From 14 July 2017 To 13 July 2047」
The company disclosed the full-year grant details for 2017 stock options for directors and audit & supervisory board members, and 84,000 shares under existing stock options were exercised. - FY2018-Q2AdvancedAnnual report
「Number of stock acquisition rights (units): 28 Number of shares underlying the stock acquisition rights (shares): 28,000 Exercise period From 14 July 2017 To 13 July 2047」
The company issued 28 stock acquisition rights for directors and audit & supervisory board members, covering 28,000 shares, with an exercise period from July 2017 to July 2047. - FY2018-Q1AdvancedAnnual report
「1 April 2017–30 June 2017 (Note 1) 145,000 16,676,157 20,527 2,851,952 20,527 3,020,352 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
In the first quarter, the number of issued shares increased by 145,000 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥20.527 million. - FY2017AdvancedAnnual report
「The stock options outstanding during the fiscal year are covered, and the number of stock options is presented on a share-equivalent basis.」
The company granted 61,000 shares in stock options to directors and audit & supervisory board members for 2016, of which 33,000 shares, including grants from prior fiscal years, were exercised. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Number of stock acquisition rights (units): 61; number of shares underlying the stock acquisition rights (shares): 61,000; exercise period: from 19 July 2016 to 18 July 2046」
The company issued 61 stock acquisition rights for directors and audit & supervisory board members, covering 61,000 shares, with an exercise period from July 2016 to July 2046.